secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2025-11-19T23:59:59+00:00
Accession:  0001193125-25-288264
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics raises ~$4M in registered direct offering paid in gold coins; redeems $3.4M note
--------------------------------------------------------------------------------

- Priced 3,540,000 shares and 8,570,203 pre-funded warrants at $0.3303/unit, gross proceeds ~$4M.
- Payment in sovereign-issued .9999 fine gold coins valued at $4,069.18/oz, intent to liquidate to USD.
- Concurrent private placement of 12,110,203 warrants at $0.3303, exercisable after stockholder approval.
- Redeemed final Promissory Note (third tranche) of $3.4M principal plus 6% premium for total $3.604M.
- Net proceeds for general corporate purposes, including debt satisfaction; offering closes Nov. 19, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000119312525288264/0001193125-25-288264-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000119312525288264/fblg-20251118.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-288264

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer